Can CGM Discriminate Between Type 1 Diabetes Patients With and Without Severe Hypoglycaemia? : Results of the Baseline Assessment from the HypoDE Study

Heinemann, LutzLutzHeinemannFreckmann, GuidoGuidoFreckmannFaber-Heinemann, GabrieleGabrieleFaber-HeinemannEhrmann, DominicDominicEhrmann0000-0002-5794-5596Hermanns, NorbertNorbertHermanns0000-0002-2903-26772019-09-192018-08-032018https://fis.uni-bamberg.de/handle/uniba/44141Abstract in: Diabetologia 60 (2017) Suppl.1 = 53rd EASD Annual Meeting of the European Association for the Study of Diabetes Lisbon, Portugal, 11 – 15 September 2017, S333 (726)severe hypoglycaemia (SH), defined as the need of third party assistance for recovery. Continuous glucose monitoring (CGM) offers valuable data about glycaemic control and hypoglycaemic exposure in these high-risk patients. However, it is unknown to which extent CGM can provide data that enables identifying people who experienced an episode of severe hypoglycaemia in the past year in this high-risk group. Therefore, we analysed baseline data of the HypoDE study to examine the following problems: 1. Is the hypoglycaemic CGM footprint different in people with and without SH? 2. Can CGM data be used to identify people with severe hypoglycaemia in this high-risk group? 3. What is the screening performance of the hypoglycaemic CGM footprint to identify people with SH?engCan CGM Discriminate Between Type 1 Diabetes Patients With and Without Severe Hypoglycaemia? : Results of the Baseline Assessment from the HypoDE Studyconferenceobjecturn:nbn:de:bvb:473-opus4-524144